Mitigation of post‐traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence
Torsten Passie, Hinderk M. Emrich, Matthias Karst, Simon D. Brandt, John H. Halpern
Drug Testing and Analysis June 26, 2012 DOI: 10.1002/dta.1377 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Case report Peer reviewed |
|---|---|
| Population | 19-year-old male patient with severe PTSD |
| Intervention | cannabis resin |
| Topics | Anxiety Cannabis PTSD |
| Keywords | Amygdala Panic Effects of cannabis Clinical psychology Endocannabinoid system |
| Citations | 114 |
| Key findings | Cannabis may reduce PTSD symptoms through synergistic mechanisms affecting endocannabinoid signaling in stress-sensitive brain regions. |
Abstract
It is known from clinical studies that some patients attempt to cope with the symptoms of post-traumatic stress disorder (PTSD) by using recreational drugs. This review presents a case report of a 19-year-old male patient with a spectrum of severe PTSD symptoms, such as intense flashbacks, panic attacks, and self-mutilation, who discovered that some of his major symptoms were dramatically reduced by smoking cannabis resin. The major part of this review is concerned with the clinical and preclinical neurobiological evidence in order to offer a potential explanation of these effects on symptom reduction in PTSD. This review shows that recent studies provided supporting evidence that PTSD patients may be able to cope with their symptoms by using cannabis products. Cannabis may dampen the strength or emotional impact of traumatic memories through synergistic mechanisms that might make it easier for people with PTSD to rest or sleep and to feel less anxious and less involved with flashback memories. The presence of endocannabinoid signalling systems within stress-sensitive nuclei of the hypothalamus, as well as upstream limbic structures (amygdala), point to the significance of this system for the regulation of neuroendocrine and behavioural responses to stress. Evidence is increasingly accumulating that cannabinoids might play a role in fear extinction and antidepressive effects. It is concluded that further studies are warranted in order to evaluate the therapeutic potential of cannabinoids in PTSD.
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
Argues that cannabis products may reduce PTSD symptoms including anxiety and flashbacks via endocannabinoid effects on stress-sensitive brain regions, based largely on a single case and preclinical evidence.
Synthesized
Comparable studies
Other narrative reviews on cannabis for anxiety, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug | 2006 | Review | |
| Partydrogen im Überblick Party drug users | 2026 | Review | |
| The Use of Illicit Drugs in Therapy: an Introduction | 2023 | Review | |
| Cannabis and psychosis: is there a role for Cannabidiol in the treatment of psychosis in young cannabis users? | 2020 | Literature review | |
| The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses. | 2023 | Review |
Citations in the library
Cited by 16
- Reviewing the Potential of Psychedelics for the Treatment of PTSD The International Journal of Neuropsychopharmacology March 12, 2020
- Clinical applications of hallucinogens: A review. Experimental and Clinical Psychopharmacology August 1, 2016
- Ayahuasca: A review of historical, pharmacological, and therapeutic aspects. Psychiatry and Clinical Neurosciences Reports December 1, 2023
- Treatment Approaches for Posttraumatic Stress Disorder Derived From Basic Research on Fear Extinction. Biological Psychiatry February 15, 2025
- The Efficacy of Psychedelic-Assisted Therapy in Managing Post-traumatic Stress Disorder (PTSD): A New Frontier? Cureus October 31, 2022
and 11 more in the library
Cites 13
- Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis Proceedings of the National Academy of Sciences December 13, 2005
- Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing Archives of General Psychiatry 2009
- Cannabinoids Elicit Antidepressant-Like Behavior and Activate Serotonergic Neurons through the Medial Prefrontal Cortex Journal of Neuroscience October 24, 2007
- Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects Frontiers in Behavioral Neuroscience 2011
- Endocannabinoid system dysfunction in mood and related disorders. Acta Psychiatrica Scandinavica October 2011
and 8 more in the library